Trial Profile
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MRZ-9547 in Healthy Subjects
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 14 Apr 2016
Price :
$35
*
At a glance
- Drugs MRZ 9547 (Primary)
- Indications Fatigue
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 14 Apr 2016 New trial record
- 08 Jun 2014 Study design presented at 18th International Congress of Parkinson's Disease and Movement Disorders.